Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice

Interruption of bile acid recirculation through inhibition of the apical sodium-dependent bile acid transporter (ASBT) is a promising strategy to alleviate hepatic cholesterol accumulation in non-alcoholic steatohepatitis (NASH), and improve the metabolic aspects of the disease. Potential disease-at...

Descripción completa

Detalles Bibliográficos
Autores principales: Salic, Kanita, Kleemann, Robert, Wilkins-Port, Cynthia, McNulty, John, Verschuren, Lars, Palmer, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590809/
https://www.ncbi.nlm.nih.gov/pubmed/31233523
http://dx.doi.org/10.1371/journal.pone.0218459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590809/
https://www.ncbi.nlm.nih.gov/pubmed/31233523
http://dx.doi.org/10.1371/journal.pone.0218459

Ejemplares similares